Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

[Determination of molecular genetic markers in acute coronary syndromes and their relationship to cardiovascular adverse events].

Canseco-Ávila LM, Jerjes-Sánchez C, Ortiz-López R, Rojas-Martínez A.

Arch Cardiol Mex. 2013 Jan-Mar;83(1):8-17. doi: 10.1016/j.acmx.2013.01.001. Spanish.

PMID:
23433583
2.

[Haemostatic and inflammation markers in acute coronary syndromes and its relationship with adverse cardiovascular events].

Díaz CJ, Núñez AC, Flores MI, Arcaute HD, Archondo T.

Arch Cardiol Mex. 2006 Oct-Dec;76(4):366-75. Spanish.

PMID:
17315612
3.

Thrombin-activatable fibrinolysis inhibitor genetic polymorphisms as markers of the type of acute coronary syndrome.

Tàssies D, Roqué M, Monteagudo J, Martorell T, Sionis A, Arzamendi D, Heras M, Reverter JC.

Thromb Res. 2009 Nov;124(5):614-8. doi: 10.1016/j.thromres.2009.07.004. Epub 2009 Aug 21.

PMID:
19699511
4.

Polymorphisms on chromosome 9p21 confer a risk for acute coronary syndrome in a Chinese Han population.

Zeng Q, Yuan Y, Wang S, Sun J, Zhang T, Qi M.

Can J Cardiol. 2013 Aug;29(8):940-4. doi: 10.1016/j.cjca.2012.11.028. Epub 2013 Mar 1.

PMID:
23454037
5.

Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).

O'Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA.

J Am Coll Cardiol. 2014 Apr 29;63(16):1644-53. doi: 10.1016/j.jacc.2013.12.034. Epub 2014 Feb 13. Erratum in: J Am Coll Cardiol. 2014 Jun 17;63(23):2642.

6.

Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome.

Tello-Montoliu A, Jover E, Marín F, Bernal A, Lozano ML, Sánchez-Vega B, Pastor FJ, Hurtado JA, Valdés M, Vicente V, Rivera J.

Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):219-26. doi: 10.1016/j.recesp.2011.07.013. Epub 2011 Nov 23. English, Spanish.

PMID:
22116003
7.

[Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein].

Borrás Pallé S, Gómez Martínez E, Romero Rodrigo A, Campos Ferrer C, Molina E, Valentín Segura V.

An Med Interna. 2002 Jun;19(6):283-8. Spanish.

PMID:
12152386
8.

Genetic polymorphisms and the cardiovascular risk of non-steroidal anti-inflammatory drugs.

St Germaine CG, Bogaty P, Boyer L, Hanley J, Engert JC, Brophy JM.

Am J Cardiol. 2010 Jun 15;105(12):1740-5. doi: 10.1016/j.amjcard.2010.01.352.

PMID:
20538124
9.

Effects of the polymorphisms of Mx1, BAT2 and CXCL12 genes on immunological traits in pigs.

Wang SJ, Liu WJ, Sargent CA, Zhao SH, Liu HB, Liu XD, Wang C, Hua GH, Yang LG, Affara NA, Zhang SJ.

Mol Biol Rep. 2012 Mar;39(3):2417-27. doi: 10.1007/s11033-011-0992-y. Epub 2011 Jun 12.

PMID:
21667240
10.

Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.

Sanchez PL, Morinigo JL, Pabon P, Martin F, Piedra I, Palacios IF, Martin-Luengo C.

Heart. 2004 Mar;90(3):264-9.

11.

Risk stratification in non-ST elevation acute coronary syndromes: predictive power of troponin I, C-reactive protein, fibrinogen and homocysteine.

Bodí V, Sanchis J, Llàcer A, Fácila L, Núñez J, Bertomeu V, Pellicer M, Chorro FJ.

Int J Cardiol. 2005 Feb 15;98(2):277-83.

PMID:
15686779
12.

4G/5G PAI-1 promoter polymorphism and acute-phase levels of PAI-1 following coronary bypass surgery: a prospective study.

Burzotta F, Iacoviello L, Di Castelnuovo A, Zamparelli R, D'Orazio A, Amore C, Schiavello R, Donati MB, Maseri A, Possati G, Andreotti F.

J Thromb Thrombolysis. 2003 Dec;16(3):149-54.

PMID:
15087600
13.

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

Hernández-Romero D, Ruiz-Nodar JM, Marín F, Tello-Montoliu A, Roldán V, Mainar L, Pérez-Andreu V, Antón AI, Bonaque JC, Valdés M, Vicente V, González-Conejero R.

Ann Med. 2010 Sep;42(6):439-46. doi: 10.3109/07853890.2010.499131.

PMID:
20673165
14.

Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up.

Mignano A, Pitruzzella V, Arnone G, Arnone MT, Rotolo A, Assennato P, Novo G, Corrado E, Novo S.

J Cardiovasc Med (Hagerstown). 2014 Jan;15(1):27-32. doi: 10.2459/JCM.0b013e328364129c.

PMID:
23867910
15.

High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.

Raposeiras Roubín S, Barreiro Pardal C, Roubín-Camiña F, Ocaranza Sanchez R, Alvarez Castro E, Paradela Dobarro B, García-Acuña JM, Aguiar Souto P, Jacquet Hervet M, Castromán MJ, Arufe I, Outes B, Reino-Maceiras MV, Abu Assi E, González-Juanatey JR.

Rev Port Cardiol. 2013 Feb;32(2):117-22. doi: 10.1016/j.repc.2012.05.026. Epub 2013 Jan 20.

PMID:
23337430
16.

Correlation between ST-T-segment changes with markers of hemostasis in patients with acute coronary syndromes.

Ehlers R, Büttcher E, Eltzschig HK, Kazmaier S, Szabo S, Helber U, Hoffmeister HM.

Cardiology. 2002;98(1-2):40-5.

PMID:
12373046
17.

Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromes.

Lekakis J, Bisti S, Tsougos E, Papathanassiou A, Dagres N, Ikonomidis I, Soteriadou E, Tselepis AD, Goudevenos J, Kremastinos DT.

Int J Cardiol. 2008 Jun 23;127(1):46-50. Epub 2007 Jun 11.

PMID:
17561290
18.

Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).

Harkness JR, Morrow DA, Braunwald E, Ren F, Lopez-Sendon J, Bode C, Budaj A, Scirica BM.

Am J Cardiol. 2011 Nov 15;108(10):1373-81. doi: 10.1016/j.amjcard.2011.06.058. Epub 2011 Sep 3.

PMID:
21890090
19.

Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.

Ozdemir O, Gundogdu F, Karakelleoglu S, Sevimli S, Pirim I, Acikel M, Arslan S, Serdar S.

Coron Artery Dis. 2008 Feb;19(1):15-9. doi: 10.1097/MCA.0b013e3282f27bf7.

PMID:
18281810
20.

[Gene polymorphisms of hemostasis and coronary risk].

Hellstern P, Bach J, Haubelt H, Preiss A, Winkelmann BR, Senges J.

Med Klin (Munich). 2001 Apr 15;96(4):217-27. Review. German.

PMID:
11370604
Items per page

Supplemental Content

Write to the Help Desk